Answers are grounded in this paper and cite their sources.
Background The novel hyaluronic acid (HA) filler, utilizing a new technology, may offer long-lasting volumization and satisfactory correction. Objective This study assessed the efficacy and safety of HA with Cha-Heart Dispersion Technology (HA-CHDT) for treating facial volume loss, providing long-lasting volumization and satisfactory correction. Methods The study included 106 healthy subjects seeking volume restoration across various facial areas, excluding the lips and infraorbital regions. Facial condition before treatment was assessed using the 5-Point Facial Volume Loss Scale (FVLS). Efficacy was evaluated through physician and subject ratings of facial volume improvement using the FVLS and the Global Aesthetic Improvement Scale (GAIS), with assessments at baseline, day 14, 6 months, and 52 weeks. Results Overall, HA-CHDT improved facial volume in all 9 facial regions, as indicated by FVLS scores from baseline through the study. Statistically significant gradual correction relative to baseline persisted to 12 months only in the nasolabial folds, temples, chin, and jawline ( p < 0.05). Subject and physician-GAIS scores also showed improved volume correction up to 12 months. Both physician and subject GAIS scores improved significantly compared with baseline ( p < 0.05). However, small sample sizes ( n = 7–9) and the conservative Bonferroni correction limited pairwise comparisons for the forehead, glabella, nasal, and marionette areas. The treatment was generally well tolerated, with only minor adverse events. Patient satisfaction was high, with most subjects indicating they would return for future treatments and recommend it to friends. Conclusions HA-CHDT can be effective, well-tolerated, and a plausible option for treating moderate-to-severe facial volume loss.
No takes yet. Share an insight, caveat, or question.
Aydın Saray (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: